Maintenance of the Remission Stage of Crohn's Disease with Adalimumab Therapy during Pregnancy
Author:
Affiliation:
1. Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Japan
Publisher
Japanese Society of Internal Medicine
Subject
General Medicine,Internal Medicine
Link
https://www.jstage.jst.go.jp/article/internalmedicine/52/10/52_52.9466/_pdf
Reference27 articles.
1. 1. Takagi S, Utsunomiya K, Kuriyama S, et al. Effectiveness of an 'half elemental diet' as maintenance therapy for Crohn's disease: a randomized-controlled trial. Aliment Pharmacol Ther 24: 1333-1340, 2006.
2. 2. Mizoshita T, Tanida S, Kusumoto S, et al. Adalimumab therapy following granulocyte and monocyte adsorptive apheresis in a patient with Crohn's disease accompanied by chronic myeloid leukemia. Clin J Gastroenterol 5: 302-306, 2012.
3. 3. Van Deventer SJ. Tumour necrosis factor and Crohn's disease. Gut 40: 443-448, 1997.
4. 4. Hanauer SB, Sandborn WJ, Rutgeerts P, et al. Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial. Gastroenterology 130: 323-333; quiz 591, 2006.
5. 5. Watanabe M, Hibi T, Lomax KG, et al. Adalimumab for the induction and maintenance of clinical remission in Japanese patients with Crohn's disease. J Crohns Colitis 6: 160-173, 2012.
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The treatment of inflammatory bowel disease with monoclonal antibodies in Asia;Biomedicine & Pharmacotherapy;2023-01
2. Pregnancy Outcomes of Patients Exposed to Adalimumab in Japan;Digestive Diseases;2018-10-10
3. Anti-Tumour Necrosis Factor α Therapies and Inflammatory Bowel Disease Pregnancy Outcomes: A Meta-analysis;Journal of Crohn's and Colitis;2016-01-11
4. Mesalazine;Reactions Weekly;2015-04
5. Does lower gastrointestinal endoscopy during pregnancy pose a risk for mother and child? – a systematic review;BMC Gastroenterology;2015-02-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3